IL8 and Cathepsin B as Melanoma Serum Biomarkers

Hongtao Zhang(Chinese Academy of Sciences), Xiaowei Xu(University of Pennsylvania), Shujing Liu(University of Pennsylvania), Suresh Kumar(University of Pennsylvania), David W. Speicher(The Wistar Institute), Suzanne McGettigan(University of Pennsylvania), Ting Fu(Deutsche Telekom (Austria)), Lynn M. Schuchter(Eastern Cooperative Oncology Group)

International Journal of Molecular Sciences

February 25, 2011

10.3390/ijms12031505

Cited by 49

Related Papers

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

|Nature|2010|1.8k

Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database

|PROTEOMICS|2005|792

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

|Journal of Clinical Oncology|1999|763

Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells

|Cancer Cell|2013|680

National Survey of Drug-Resistant Tuberculosis in China

|New England Journal of Medicine|2012|649